2008Jiangsu Medical JournalRequires access

Evaluation of contrast-enhanced ultrasonography in differentiating benign and malignant hepatic lesions

Xinhua Ye

Open publisher page 0 citations

Abstract

Objective To investigate the value of contrast-enhanced sonography in differential diagnosis of benign and malignant focal hepatic lesions. Methods Malignant(91 cases) and benign(63 cases) lesions of the liver were examined by GE-LOGIQ9 and Technos MPX DU8 color Doppler ultrasound system with contrast-enhanced ultrasonography software and sonovue.The engorged process and type, enhanced extent of hepaticparenchyma and masses were recorded. Results 96.7%(88/91) malignant lesions showed contrast enhancement in the early phase,and 97.8%(89/91) malignant lesions showed hypoechoic in the late phase. 50.8%(32/63) benign lesions showed contrast enhancement in the early phase,and 96.8%(61/63) benign lesions showed isoechoic and hyperechoic in the late phase. Conclusion Contrast-enhanced sonography with sonovue has a greater clinical value in the differentiation of benign and malignant liver lesions.

About this research paper

What this paper is about

Objective To investigate the value of contrast-enhanced sonography in differential diagnosis of benign and malignant focal hepatic lesions. Methods Malignant(91 cases) and benign(63 cases) lesions of the liver were examined by GE-LOGIQ9 and Technos MPX DU8 color Doppler ultrasound system with contrast-enhanced ultrasonography software and sonovue.The engorged process and type, enhanced extent of hepaticparenchyma and masses were recorded. Results 96.7%(88/91) malignant lesions showed contrast enhancement in the early phase,and 97.8%(89/91) malignant lesions showed hypoechoic in the late phase. 50.8%(32/63) benign lesions showed contrast enhancement in the early phase,and 96.8%(61/63) benign lesions showed isoechoic and hyperechoic in the late phase. Conclusion Contrast-enhanced sonography with sonovue has a greater clinical value in the differentiation of benign and malignant liver lesions.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the value of contrast-enhanced sonography in differential diagnosis of benign and malignant focal hepatic lesions. Methods Malignant(91 cases) and benign(63 cases) lesions of the liver were examined by GE-LOGIQ9 and Technos MPX DU8 color Doppler ultrasound system with contrast-enhanced ultrasonography software and sonovue.The engorged process and type, enhanced extent of hepaticparenchyma and masses were recorded. Results 96.7%(88/91) malignant lesions showed contrast enhancement in the early phase,and 97.8%(89/91) malignant lesions showed hypoechoic in the late phase. 50.8%(32/63) benign lesions showed contrast enhancement in the early phase,and 96.8%(61/63) benign lesions showed isoechoic and hyperechoic in the late phase. Conclusion Contrast-enhanced sonography with sonovue has a greater clinical value in the differentiation of benign and malignant liver lesions.

Key concepts: Medicine, Differential diagnosis, Ultrasonography, Radiology, Ultrasound, Contrast enhancement, Contrast (vision), Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Evaluation of contrast-enhanced ultrasonography in differentiating benign and malignant hepatic lesions — Research Paper | ScholarLens